Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 31, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 28,750 | $14.74 | 163,204 | |
| Aug 31, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 28,750 | -- | 1,250 | |
| Sep 01, 2020 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | $5.96 | 880,713 | |
| Sep 01, 2020 | Director, Chairman & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 29,900 | $14.18 | 850,813 | |
| Sep 01, 2020 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | -- | 43,975 | |
| Sep 01, 2020 | Director | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,500 | $14.62 | 33,967 | |
| Sep 02, 2020 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 20 | |
| Sep 02, 2020 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Sep 28, 2020 | Director, Chief Operating Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 24,782 | $2.52 | 363,546 | |
| Sep 28, 2020 | Director, Chief Operating Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 24,782 | $13.89 | 338,764 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.